Manning Paul B (CIK 1494695) reported 18 SEC Form 4 insider transactions across 4 companies over the past 18 months (most recent 2026-06-18). Recent activity: Buy LQDA (5,882 shares), Sell LQDA (88,487 shares), Sell LQDA (11,513 shares), Sell LQDA (19,125 shares), Sell LQDA (68,265 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-18 | Liquidia Corp (LQDA) | Director | Buy | 5,882 | $0 |
| 2026-06-08 | Liquidia Corp (LQDA) | Director | Sell | 88,487 | $5.7M |
| 2026-06-08 | Liquidia Corp (LQDA) | Director | Sell | 11,513 | $726,816 |
| 2026-06-08 | Liquidia Corp (LQDA) | Director | Sell | 19,125 | $1.2M |
| 2026-06-08 | Liquidia Corp (LQDA) | Director | Sell | 68,265 | $4.4M |
| 2026-06-08 | Liquidia Corp (LQDA) | Director | Sell | 12,610 | $812,336 |
| 2026-02-26 | Candel Therapeutics, Inc. (CADL) | Director | Buy | 550,458 | $3.0M |
| 2026-02-12 | Liquidia Corp (LQDA) | Director | Sell | 55,116 | $2.3M |
| 2026-02-12 | Liquidia Corp (LQDA) | Director | Buy | 55,116 | $2.3M |
| 2025-11-25 | Verrica Pharmaceuticals Inc. (VRCA) | Director | Buy | 1.4M | $5.8M |
| 2025-11-25 | Verrica Pharmaceuticals Inc. (VRCA) | Director | Buy | 2.8M | $11.7M |
| 2025-09-02 | Liquidia Corp (LQDA) | Director | Sell | 154,337 | $4.3M |
| 2025-09-02 | Liquidia Corp (LQDA) | Director | Sell | 188,232 | $5.2M |
| 2025-09-02 | Liquidia Corp (LQDA) | Director | Sell | 254,038 | $7.3M |
| 2025-09-02 | Liquidia Corp (LQDA) | Director | Sell | 74,230 | $2.2M |
| 2025-06-26 | Candel Therapeutics, Inc. (CADL) | Director | Buy | 1.1M | $5.0M |
| 2025-06-20 | Liquidia Corp (LQDA) | Director | Buy | 18,396 | $0 |
| 2025-06-03 | Taysha Gene Therapies, Inc. (TSHA) | Insider | Buy | 750,000 | $2.1M |
Source: SEC Form 4 filings · as of 2026-06-18